Skip to main navigation Skip to search Skip to main content

An ionic contrast agent inhibits platelet-dependent thrombin generation and boosts the effect of abciximab.

Research output: Contribution to journalArticleAcademicpeer-review

348 Downloads (Pure)
Original languageEnglish
Pages (from-to)944-945
JournalThrombosis and Haemostasis
Volume85
DOIs
Publication statusPublished - 1 Jan 2001

Cite this